DYNLT3 and breast carcinoma: Our results showed that the apoptosis rate was reduced in DYNLT3‐overexpressed MDA‐MB‐231 breast cancer cells, and reversed in DYNLT3‐knockdown MDA‐MB‐231 and MCF‐7 breast cancer cells.